{"id":61682,"date":"2025-08-04T16:05:53","date_gmt":"2025-08-04T14:05:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/"},"modified":"2025-08-04T16:05:53","modified_gmt":"2025-08-04T14:05:53","slug":"hkw-partners-with-alimed","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/","title":{"rendered":"HKW Partners with AliMed"},"content":{"rendered":"
\n

INDIANAPOLIS–(BUSINESS WIRE)–HKW, a middle-market private equity firm focused on growth companies, has partnered with the Cherubini family to recapitalize AliMed Inc. (\u201cAliMed\u201d).<\/p>\n

<\/a>
<\/a><\/p>\n

\nAliMed is a national provider of branded medical products headquartered in Dedham, MA. Founded in 1970, AliMed serves over 15,000 acute and non-acute care facilities, including hospitals, surgery centers, nursing homes and long-term care facilities.<\/p>\n

\n\u201cOver 55 years ago, my parents founded AliMed with a focus on quality and service,\u201d Alexandra Cherubini said. \u201cPartnering with HKW honors that legacy and accelerates our growth as we work to deliver even more to our healthcare community.\u201d<\/p>\n

\n\u201cAliMed is a great fit with HKW\u2019s strategy of partnering with family-owned businesses to unlock potential growth and profitability opportunities,\u201d Devraj Roy, Partner at HKW, said. \u201cThe Cherubini family has invested heavily in management talent, digital capabilities, and in developing the AliMed brand. We\u2019re excited to build on this foundation while bringing our experience in specialty manufacturing and distribution businesses serving the healthcare market. We will seek to accelerate organic growth as well as pursue logical acquisitions.\u201d<\/p>\n

\nThe financial terms of the transaction were not disclosed.<\/p>\n

\nAbout AliMed<\/b><\/p>\n

\nAliMed manufactures and distributes acute and non-acute medical products and devices. For over 50 years, AliMed has delivered flexible supply chain solutions, compelling customer service, and high-quality products focused on enhancing clinician safety and empowering caregivers to create positive patient experiences that lead to better outcomes. For more information on AliMed, please visit alimed.com.<\/p>\n

\nAbout HKW<\/b><\/p>\n

\nHKW is a middle-market private equity firm investing in companies with talented management teams in the US and Canada. HKW targets companies in the manufacturing, distribution and business services sectors. Since 1982, HKW has sponsored 72 platform transactions of lower middle-market companies throughout North America and 80 add-on acquisitions. For more information on HKW, please visit hkwinc.com<\/a>.<\/p>\n

\nAdvisors<\/b><\/p>\n

\nTaft Stettinius & Hollister LLP served as legal advisor to HKW. North Point Mergers & Acquisitions served as financial advisor and Williams Mullen served as legal advisor to AliMed.<\/p>\n

Contacts<\/b> <\/p>\n

\nJim Snyder
\n
jcs@hkwinc.com<\/a>
(317) 590-7401<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

INDIANAPOLIS–(BUSINESS WIRE)–HKW, a middle-market private equity firm focused on growth companies, has partnered with the Cherubini family to recapitalize AliMed Inc. (\u201cAliMed\u201d). AliMed is a national provider of branded medical products headquartered in Dedham, MA. Founded in 1970, AliMed serves over 15,000 acute and non-acute care facilities, including hospitals, surgery centers, nursing homes and long-term … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61682","6":"format-standard","7":"category-industry"},"yoast_head":"\nHKW Partners with AliMed - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HKW Partners with AliMed - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"INDIANAPOLIS–(BUSINESS WIRE)–HKW, a middle-market private equity firm focused on growth companies, has partnered with the Cherubini family to recapitalize AliMed Inc. (\u201cAliMed\u201d). AliMed is a national provider of branded medical products headquartered in Dedham, MA. Founded in 1970, AliMed serves over 15,000 acute and non-acute care facilities, including hospitals, surgery centers, nursing homes and long-term ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-04T14:05:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250804480634\/en\/1643338\/22\/hkw_RGB-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"HKW Partners with AliMed\",\"datePublished\":\"2025-08-04T14:05:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/\"},\"wordCount\":337,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250804480634\\\/en\\\/1643338\\\/22\\\/hkw_RGB-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/\",\"name\":\"HKW Partners with AliMed - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250804480634\\\/en\\\/1643338\\\/22\\\/hkw_RGB-01.jpg\",\"datePublished\":\"2025-08-04T14:05:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250804480634\\\/en\\\/1643338\\\/22\\\/hkw_RGB-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250804480634\\\/en\\\/1643338\\\/22\\\/hkw_RGB-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hkw-partners-with-alimed\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HKW Partners with AliMed\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HKW Partners with AliMed - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/","og_locale":"en_US","og_type":"article","og_title":"HKW Partners with AliMed - Pharma Trend","og_description":"INDIANAPOLIS–(BUSINESS WIRE)–HKW, a middle-market private equity firm focused on growth companies, has partnered with the Cherubini family to recapitalize AliMed Inc. (\u201cAliMed\u201d). AliMed is a national provider of branded medical products headquartered in Dedham, MA. Founded in 1970, AliMed serves over 15,000 acute and non-acute care facilities, including hospitals, surgery centers, nursing homes and long-term ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-04T14:05:53+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250804480634\/en\/1643338\/22\/hkw_RGB-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"HKW Partners with AliMed","datePublished":"2025-08-04T14:05:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/"},"wordCount":337,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250804480634\/en\/1643338\/22\/hkw_RGB-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/","url":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/","name":"HKW Partners with AliMed - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250804480634\/en\/1643338\/22\/hkw_RGB-01.jpg","datePublished":"2025-08-04T14:05:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250804480634\/en\/1643338\/22\/hkw_RGB-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250804480634\/en\/1643338\/22\/hkw_RGB-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/hkw-partners-with-alimed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"HKW Partners with AliMed"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61682"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61682\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}